Clinical Trials Browser

Phase NA × Simpson-Golabi-Behmel syndrome × Clear all

Simpson-Golabi-Behmel syndrome, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Digestive System Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04728139 2022-01-13

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

Phase NA Unknown

90 enrolled

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Colorectal Neoplasms

Clinical Trials

Target-specific immunoPET Imaging of Digestive System Carcinoma

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients